These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 25669949)
1. [The genetics of antipsychotic-related movement disorders]. Bakker PR; van Os J; van Harten PN Tijdschr Psychiatr; 2015; 57(2):114-9. PubMed ID: 25669949 [TBL] [Abstract][Full Text] [Related]
2. Genetics of tardive dyskinesia. Lee HJ; Kang SG Int Rev Neurobiol; 2011; 98():231-64. PubMed ID: 21907090 [TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and tardive dyskinesia: pharmacogenetic evidence. Cho CH; Lee HJ Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():207-13. PubMed ID: 23123399 [TBL] [Abstract][Full Text] [Related]
4. [Risk factors for tardive movement disorders in schizophrenia]. Tenback DE; Bakker PR; van Harten PN Tijdschr Psychiatr; 2015; 57(2):120-4. PubMed ID: 25669950 [TBL] [Abstract][Full Text] [Related]
5. Candidate gene-based association study of antipsychotic-induced movement disorders in long-stay psychiatric patients: a prospective study. Bakker PR; Bakker E; Amin N; van Duijn CM; van Os J; van Harten PN PLoS One; 2012; 7(5):e36561. PubMed ID: 22615781 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of tardive dyskinesia: an updated review of the literature. Lanning RK; Zai CC; Müller DJ Pharmacogenomics; 2016 Aug; 17(12):1339-51. PubMed ID: 27469238 [TBL] [Abstract][Full Text] [Related]
7. [Genome-wide association analyses for neuroleptic-induced tardive dyskinesia]. Arinami T; Inada T Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Aug; 31(4):155-62. PubMed ID: 21941849 [TBL] [Abstract][Full Text] [Related]
8. The catechol-O-methyl-transferase gene in tardive dyskinesia. Zai CC; Tiwari AK; Müller DJ; De Luca V; Shinkai T; Shaikh S; Ni X; Sibony D; Voineskos AN; Meltzer HY; Lieberman JA; Potkin SG; Remington G; Kennedy JL World J Biol Psychiatry; 2010 Sep; 11(6):803-12. PubMed ID: 20586531 [TBL] [Abstract][Full Text] [Related]
9. Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics. Thelma B; Srivastava V; Tiwari AK Pharmacogenomics; 2008 Sep; 9(9):1285-306. PubMed ID: 18781856 [TBL] [Abstract][Full Text] [Related]
10. The pharmacogenetics of antipsychotic treatment. Reynolds GP Handb Exp Pharmacol; 2012; (212):213-39. PubMed ID: 23129334 [TBL] [Abstract][Full Text] [Related]
11. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)]. Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575 [TBL] [Abstract][Full Text] [Related]